Secondary Outcome(s)
|
Change in calcemia (mg/l)
[Time Frame: Day 1]
|
Change in calcemia (mg/l)
[Time Frame: Day 7 to 15]
|
Change in parathormonemia (ng/l)
[Time Frame: Days 7 to 15]
|
Change in parathormonemia (ng/l)
[Time Frame: Day 1]
|
Operating room prep time (min)
[Time Frame: 1 day]
|
Change in calcemia (mg/l)
[Time Frame: 12 months]
|
Change in phosphoremia (mg/l)
[Time Frame: Days 7 to 15]
|
Change in phosphoremia (mg/l)
[Time Frame: Day 1]
|
Change in thyroglobulinemia (ng/l)
[Time Frame: 12 months]
|
Direct medical costs (€)
[Time Frame: 12 months]
|
Indirect medical costs (€)
[Time Frame: 12 months]
|
Incision size (mm)
[Time Frame: 12 months]
|
Presence/absence of conversion to open technique
[Time Frame: 1 day]
|
Visual Analog Pain Score
[Time Frame: 12 months]
|
Patient satisfaction score
[Time Frame: 12 months]
|
Change in phosphoremia (mg/l)
[Time Frame: 12 months]
|
Visual Analog Pain Score
[Time Frame: Days 7 to 15]
|
Change in parathormonemia (ng/l)
[Time Frame: 12 months]
|
Hospital stay (d)
[Time Frame: 7 to 15 days post-op]
|
Presence/absence of per-operative complications
[Time Frame: 1 day]
|
Visual Analog Pain Score
[Time Frame: Day 1]
|